drugset / Trial / NCT00443417
A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to find optimistic dose and to evaluate the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease.
Timeline
- Start
- 2007-04
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SK-PC-B70M | Unknown | 200 mg | — |
| Comparator | SK-PC-B70M | Unknown | 400 mg | — |